Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Clinical trial NCT05031949 · UNKNOWN

Trial details

NCT number: NCT05031949
Sponsor: Zhang Bi Xiang, MD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Combinational Immunotherapy Hepatocellular Carcinoma Non-Resectable Hyperbaric Oxygen Therapy

Start date: 2021-10-30
Primary completion: 2024-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.